Lirum Therapeutics Balance Sheet Health
Financial Health criteria checks 5/6
Lirum Therapeutics has a total shareholder equity of $2.4M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $4.6M and $2.2M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
Interest coverage ratio | n/a |
Cash | US$4.01m |
Equity | US$2.39m |
Total liabilities | US$2.18m |
Total assets | US$4.57m |
Recent financial health updates
No updates
Recent updates
No updates
Financial Position Analysis
Short Term Liabilities: LRTX's short term assets ($4.6M) exceed its short term liabilities ($2.2M).
Long Term Liabilities: LRTX has no long term liabilities.
Debt to Equity History and Analysis
Debt Level: LRTX is debt free.
Reducing Debt: LRTX had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: LRTX has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: LRTX has less than a year of cash runway if free cash flow continues to reduce at historical rates of 104.3% each year